Original paper

Atorvastatin alleviates experimental diabetic cardiomyopathy by suppressing apoptosis and oxidative stress

Volume: 46, Issue: 4-5, Pages: 337 - 345
Published: Jun 4, 2015
Abstract
Diabetic hazard on the myocardium is a complication of diabetes that intensifies its morbidity and increases its mortality. Therefore, alleviation of diabetic cardiomyopathy (DCM) by a reliable drug remains a matter of interest in experimental research. The aim of this study was to explore the structural alterations in the myocardium induced by atorvastatin (ATOR) in DCM, induced by streptozotocin (STZ), along with the associated changes...
Paper Details
Title
Atorvastatin alleviates experimental diabetic cardiomyopathy by suppressing apoptosis and oxidative stress
Published Date
Jun 4, 2015
Volume
46
Issue
4-5
Pages
337 - 345
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.